Siddharth Mittal, CEO of Biocon, on plans by Indian pharmaceutical makers to create generic versions of drugs from Western countries: “When the generics come in there will be a huge price war. There is a huge demand for these drugs at the right price.”
Fiona Czerniawska, CEO of Source Global Research, a consulting sector analyst, on major consulting firms delaying start dates for their new recruits: “The second half of this year has been a bit less buoyant than people were hoping for. When most firms look at their pipelines of future work, they’re very strong, but it’s taking longer for that work to come through.”
Dan Huot, SpaceX communications manager, on the company’s technical feat of catching a booster rocket with mechanical arms on its return from a test flight: “Even in this day and age, what we just saw is magic. I am, like, shaking right now.”